Atrioventricular blocks occurring during transcatheter aortic valve replacement differ from those occurring after the ...

Hospitalizations for bronchiectasis exacerbations are associated with poorer in-hospital outcomes than those for chronic obstructive pulmonary disease or asthma exacerbations.

Sacituzumab does not improve outcomes vs chemotherapy when used as the first treatment after endocrine therapy failure in HR+/HER2- advanced breast cancer, the ASCENT-07 trial finds.

Despite increased labeling of drugs with pediatric information, most medicines remain available only as pills meant for ...

Patient demand is driving a shift in mastectomy care. Dr Lisa Hunsicker discusses why sensation loss is a traumatic reality for many patients and how neurotization is becoming the new standard.

The report charts major advances in precision oncology and immunotherapy but also reveals stagnant survival for several ...

In the phase 3 COBRA trial, the carfilzomib/lenalidomide/dexamethasone regimen shows significant improvements in PFS and other outcomes in newly diagnosed MM, including in patients at cytogenic risk.

Dr Nayiri Guedikian discusses the SOAP format for clinical notes, demonstrating how they improve clarity, continuity of care, and patient safety.

Semaglutide, a GLP-1 receptor agonist (RA), was associated with a significantly lower risk for adult-onset epilepsy in patients with diabetes than other glucose-lowering drugs (GLDs). Notably, this ...

A chemotherapy-free-based regimen of the TKI ponatinib combined with targeted immunotherapy showed significant benefits in ...

Other signs of potential FH include yellowish fatty collections called xanthomas seen under the skin; around the eyes; or at the back of the hands, palms, or soles or a gray ring called a corneal ...

Patients with oropharyngeal carcinoma who receive proton therapy are more likely to develop this potentially debilitating complication than those who receive IMRT, a new study finds.